NATURE REVIEWS DRUG DISCOVERY - Impact Factor, Quartile, Ranking

» NATURE REVIEWS DRUG DISCOVERY

Abbreviation:

NAT REV DRUG DISCOV

ISSN:

1474-1776

eISSN:

1474-1784

Category:

PHARMACOLOGY & PHARMACY - SCIE
BIOTECHNOLOGY & APPLIED MICROBIOLOGY - SCIE

WoS Core Citation Indexes:

SCIE - Science Citation Index Expanded

Journal Impact Factor (JIF):

122.7

5-year Impact Factor:

114.9

Best ranking:

PHARMACOLOGY & PHARMACY (Q1) ― Percentage rank: 99.7%

Open Access Support:

Hybrid and Open Access Support

Country:

ENGLAND

Status in WoS core:

Active

Publisher:

N/A

Check with Clarivate MJL »

Check with SCIMAGO »

Check with SCOPUS »

Check with ISSN »

» In order to submit a manuscript to this journal, please read the guidelines for authors in the journal's homepage.

» For a more in-depth analysis of the journal, you should subscribe and check it out on Journal Citation Reports (JCR).

» If you need a journal template (Word or Latex), you can read this entry.

» Journals of ESCI (except for fields of Arts and Humanities) are now ranked by JIF as the same with journals of SCIE and SSCI in the release of JCR 2023 (in 2024). Journals of AHCI and ESCI of Arts and Humanities are not ranked.

» Open access (OA) journals are free for readers. To maintain the business model, publishers will account for publication fees from authors, but some funds may cover the fees, and OA journals may not charge any fees.